| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
132.32(B) |
| Last
Volume: |
12,670,091 |
Avg
Vol: |
8,037,102 |
| 52
Week Range: |
$88.03 - $108.14 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 39 |
| Guru Rank Value : 15.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,515 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
143,095 |
317,309 |
1,137,861 |
2,394,882 |
| Total Sell Value |
$14,228,732 |
$32,626,151 |
$116,650,545 |
$214,284,391 |
| Total People Sold |
3 |
5 |
11 |
14 |
| Total Sell Transactions |
6 |
12 |
46 |
89 |
| End Date |
2025-09-11 |
2025-06-10 |
2024-12-10 |
2023-12-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Oconnor Padraig Andrew |
EVP, Global OperationsOfficer |
|
2025-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,885 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-12-01 |
4 |
AS |
$101.55 |
$1,758,189 |
D/D |
(17,313) |
23,600 |
|
-3% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-12-01 |
4 |
OE |
$17.26 |
$429,491 |
D/D |
17,313 |
40,913 |
|
- |
|
Osullivan Miriam |
SVP, Chief HR Officer |
|
2025-11-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
260 |
14,797 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-11-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,610 |
168,042 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
690 |
177,652 |
|
- |
|
Zane Ellen M |
Director |
|
2025-11-06 |
4 |
AS |
$98.28 |
$1,266,978 |
D/D |
(12,891) |
24,134 |
|
-2% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-11-03 |
4 |
AS |
$99.14 |
$4,973,338 |
D/D |
(50,000) |
178,342 |
|
-1% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-11-03 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2025-10-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
149,992 |
213,679 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2025-10-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
162,193 |
363,671 |
|
- |
|
Zane Ellen M |
Director |
|
2025-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,891 |
37,025 |
|
- |
|
Zane Ellen M |
Director |
|
2025-10-28 |
4 |
AS |
$102.24 |
$296,599 |
D/D |
(2,901) |
24,134 |
|
-3% |
|
Zane Ellen M |
Director |
|
2025-10-27 |
4 |
AS |
$101.13 |
$1,010,301 |
D/D |
(9,990) |
27,035 |
|
-5% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-10-01 |
4 |
AS |
$98.38 |
$4,923,327 |
D/D |
(50,000) |
178,342 |
|
2% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-10-01 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-09-02 |
4 |
AS |
$104.89 |
$5,271,416 |
D/D |
(50,000) |
178,342 |
|
-9% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-09-02 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Monson Jonathan |
EVP and CFO |
|
2025-08-02 |
4 |
D |
$105.41 |
$55,656 |
D/D |
(528) |
35,289 |
|
- |
|
Monson Jonathan |
EVP and CFO |
|
2025-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,090 |
35,817 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-08-01 |
4 |
AS |
$104.63 |
$1,811,520 |
D/D |
(17,313) |
23,600 |
|
-7% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-08-01 |
4 |
OE |
$17.26 |
$429,493 |
D/D |
17,313 |
40,913 |
|
- |
|
Ludwig Edward J |
Director |
|
2025-08-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
17,979 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-08-01 |
4 |
AS |
$104.63 |
$5,231,670 |
D/D |
(50,000) |
178,342 |
|
-7% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-08-01 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
2520 Records found
|
|
Page 1 of 101 |
|
|